Legality of 10-OH-HHC in France: Status Update in 2025

In-depth analysis of the legal status of 10-OH-HHC (10-hydroxy-hexahydrocannabinol) in France in light of recent ANSM decisions, supported by official sources and commercial practices.

Introduction

10-OH-HHC (10-hydroxy-hexahydrocannabinol) is a molecule from the cannabinoid family, derived from HHC (hexahydrocannabinol). Recently introduced to the European market, it is drawing growing interest in scientific, regulatory, and commercial sectors due to its ambiguous legal status. This article provides a comprehensive overview of the regulatory position of 10-OH-HHC in France, based in particular on an official response from the French National Agency for Medicines and Health Products Safety (ANSM) dated October 2024.

Chemical Structure and Properties

10-OH-HHC is a hydroxylated metabolite of HHC, obtained either through natural enzymatic transformation in the body or via synthetic laboratory processes. It differs from HHC by the addition of a hydroxyl (OH) group at the 10-position on the benzochromene ring. This modification affects its polarity, bioavailability, and potentially its pharmacodynamic effects. Although scientific data is still limited, preliminary studies suggest an action profile close to that of HHC, but with lower potency than THC.

French Regulatory Framework

In May 2024, the ANSM updated the list of narcotic substances, adding several synthetic cannabinoids including HHC, HHC-acetate, and related analogues. However, 10-OH-HHC was not explicitly listed.

This statement, published by GrosBuzz.com, was interpreted as a temporary confirmation of the legality of 10-OH-HHC in France. However, this stance could evolve depending on scientific findings or misuse of the molecule.

Legal and Commercial Considerations

Since it is not listed as a narcotic, the marketing of 10-OH-HHC in France is legally permissible, provided the products comply with applicable rules for food supplements or technical products. Sellers must ensure full traceability, provide independent laboratory certificates (COA), and comply with EU chemical regulations (REACH).

GrosBuzz’s Role in Responsible Distribution

GrosBuzz, a reputable French distributor, stands out by publishing official documents and offering transparent information to clients. By providing 10-OH-HHC products that are tested and legally compliant, the company positions itself as a legitimate and responsible player in the emerging cannabinoid market.

Regulatory Outlook

As with any new cannabinoid, the legal standing of 10-OH-HHC may change quickly. The ANSM, in collaboration with the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), is monitoring the emergence of new psychoactive substances. Future listing of 10-OH-HHC as a controlled substance is not excluded. Industry professionals are advised to stay informed through official channels.

Conclusion

10-OH-HHC is currently legal in France, as confirmed by the ANSM in October 2024. This opens the way for regulated commercial use. However, regulatory vigilance and corporate responsibility are crucial. Platforms like GrosBuzz.com serve a vital role in providing reliable information to both professionals and consumers.

Sources:

• Official ANSM response regarding 10-OH-HHC, October 16, 2024 (document available on GrosBuzz.com)
• ANSM: Newly listed synthetic cannabinoids

Preview of the original document: